RxDoctor Payments Data

Lu Ann Bundrant

Internal Medicine · Austin, TXNPI 1700812989

Payments from drug & device makers

What this record shows

That places this record below the midpoint for internal medicine clinicians in TX, where the typical reported total is $270.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$5,446,337in research payments, 2019–2025

Across 56 payments — averaging $97,256 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Viiv Healthcare Company$2.7M
  • Noven Pharmaceuticals, Inc.$1.7M
  • E.r. Squibb & Sons, L.L.C.$607K
  • Biocryst Pharmaceuticals, Inc.$400K
  • Bayer$38K
  • Sunovion Pharmaceuticals Inc.$2K
  • plus $2K from 1 others

How this compares

$0 in reported general payments places this provider in the 10th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas →

Other internal medicine in Austin

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →